pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Moderna, Inc. ($MRNA) · news · pharmadog
← back to Moderna, Inc.
News mentioning $MRNA
102
stories
4h
Capricor investor calls for change as company awaits decision on Duchenne candidate
biospace
4h
STAT+: HHS document offers new clues to Kennedy’s vaccine plans
stat
7h
STAT+: Up and down the ladder: The latest comings and goings
stat
7h
STAT+: Pharmalittle: We’re reading about a big Roche investment in the U.S., estrogen patch shortages, and more
stat
1d
STAT+: FDA approves Ultragenyx gene therapy
stat
1d
Contrasting legal decisions on gender-affirming care
stat
1d
STAT+: Pharmalittle: We’re reading about a Regeneron rare disease drug, an Ultragenyx gene therapy, and more
stat
1d
Merck’s Moderna-partnered vaccine success clears view of post-Keytruda future
biospace
1d
STAT+: One of the most consequential years for cancer treatment, ever
stat
1d
Merck-Moderna cancer vaccine win spurs stock jump, speculation of Keytruda-like impact
fiercebiotech
1d
Opinion: Capricor’s Duchenne muscular dystrophy drug and the countless tiny decisions that can make or break a study
stat
1d
7 biopharma M&A deals where layoffs followed
biospace
2d
Trump's FDA pick Overton good for psychedelics, new pain meds but bad for vaccines: Analysts
biospace
2d
STAT+: Experts scrutinize Huidagene’s disclosures after patient death
stat
2d
STAT+: Regeneron drug for disease that causes dangerous bone growth earns FDA approval
stat
2d
STAT+: American Cancer Society cancels alcohol industry fundraiser
stat
2d
STAT+: Brain organoids, kept alive more than five years, matured like human brains
stat
2d
Kolon TissueGene cuts 37 US staffers after Phase 3 fail
biospace
2d
11 companies hiring in New Jersey
biospace
2d
Moderna stock nearly doubles as Merck-partnered mRNA cancer vaccine meets Phase 3 goal
biospace
2d
STAT+: Pharmalittle: We’re reading about an FDA commish nominee, mRNA cancer vaccine results, and more
stat
2d
Moderna and Merck cancer vaccine returns ‘landmark’ result in melanoma
biopharma dive
2d
Dissecting Chinese trial strategy in wake of deaths
stat
2d
Merck, Moderna declare Phase 3 success for personalized mRNA cancer vaccine
endpoints
2d
STAT+: Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial
stat
2d
Merck, Moderna’s personalized cancer vaccine slows recurrence in phase 3, setting up approval push
fiercebiotech
4d
FDA nod is just the first hurdle for Moderna’s potential blockbuster flu vax
biopharma dive
7d
Capricor soars on potential FDA review extension, filing amendments
biospace
9d
BridgeBio continues ATTR ascent as Alnylam’s Amvuttra falls short of expectations
biospace
9d
With tech backing, AI biotechs force biopharma into ‘fail-fast’ drug development
biospace
← prev
page 1 of 4
next →
